Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 346 participants.

Also called NCT05931224

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 346 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05931224
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05931224. Randomized; double masking; primary purpose treatment. Start 2023-06-28 (actual); primary completion 2024-05-13 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy
Condition
Essential Hypertension
Intervention (Drug)
D064, D702, placebo of D660
Intervention (Drug)
D660, placebo of D064, placebo of D702
Lead sponsor
Chong Kun Dang Pharmaceutical (class: industry)

Record details

Record id
cardio:ct-nct05931224
Content hash
5ed125d5d352e66fcb69c30563d66e3cb89e62d9613c2813be49015b10ed7a19